Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Stable Angina | p. 1 |
Definition and Pathophusiology | p. 1 |
Pathophysiology | p. 1 |
Diagnosis | p. 2 |
Signs and Symptoms | p. 2 |
The Electrocardiogram | p. 3 |
Differential Diagnosis | p. 4 |
Stress Testing | p. 4 |
Treatment | p. 5 |
Aspirin | p. 5 |
Antianginals: Nitrates | p. 6 |
Antianginals: ß-Blockers | p. 7 |
Antianginals: Calcium Channel Blockers | p. 7 |
Antianginals: Ranolazine | p. 8 |
Blood Pressure Control | p. 8 |
Angiotensin-Converting Enzyme Inhibitors | p. 8 |
Cholesterol Reduction | p. 9 |
Cigarette Smoking | p. 10 |
Diet | p. 11 |
Diabetes | p. 11 |
Exercise | p. 12 |
Education | p. 12 |
Revascularization | p. 13 |
References | p. 15 |
Acute Coronary Syndromes | p. 19 |
Definition | p. 19 |
Pathophysiology | p. 19 |
Diagnosis | p. 20 |
Signs and Symptoms | p. 20 |
The Electrocardiogram | p. 21 |
ST Elevation Myocardial Infarction | p. 23 |
Thrombolytic Therapy | p. 23 |
Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction | p. 25 |
Adjunctive Therapies in STEMI | p. 27 |
Non-ST Elevation Myocardial Infaction | p. 33 |
Antiplatelet Therapy | p. 34 |
Anticoagulant Therapy | p. 35 |
Glycoprotein IIb/IIIa Antagonists | p. 36 |
Interventional Management | p. 36 |
Complications of Acute Myocardial Infarction | p. 38 |
Postinfarction Ischemia | p. 38 |
Ventricular Free Wall Rupture | p. 39 |
Ventricular Septal Rupture | p. 39 |
Acute Mitral Regurgitation | p. 39 |
Right Ventricular Infarction | p. 40 |
Cardiogenic Shock | p. 41 |
References | p. 45 |
Arrhythmias | p. 51 |
Introduction | p. 51 |
Arrhythmia Diagnosis | p. 51 |
Basic Principles | p. 51 |
Classification of Arrhythmias | p. 52 |
Rhythm Diagnosis | p. 52 |
Atrial Fibrillation | p. 53 |
Etiology and Pathophysiology | p. 53 |
Clinical Features | p. 55 |
Therapy | p. 55 |
Supraventricular Tachycardia | p. 61 |
Sinus Tachycardia | p. 61 |
Focal (Ectopic) Atrial Tachycardia | p. 62 |
Multifocal Atrial Tachycardia | p. 63 |
AV Nodal Reentry Tachycardia | p. 63 |
Atrioventricular Reciprocating Tachycardia | p. 64 |
Junctional Tachycardia | p. 67 |
Ventricular Tachycardia | p. 68 |
Torsade de Pointes | p. 70 |
Long QT Syndrome | p. 71 |
Arrhythmogenic Right Ventricular Dysplasia | p. 72 |
Brugada Syndrome | p. 73 |
Bradycardias | p. 73 |
References | p. 77 |
Hypertension | p. 81 |
Etiology and Pathophysiology | p. 81 |
Diagnosis | p. 82 |
Therapy | p. 83 |
Compelling Indications | p. 85 |
References | p. 87 |
Congestive Heart Failure | p. 91 |
Definition and Epidemiology | p. 91 |
Pathophysiologt | p. 92 |
Diagnosis | p. 94 |
Therapy | p. 96 |
Treatment Goals | p. 96 |
General Measures | p. 96 |
Pharmacologic Therapy | p. 97 |
Diuretics | p. 97 |
Nitrates | p. 98 |
Angiotensin-Converting Enzyme Inhibitors | p. 99 |
Angiotensin Receptor Blockers | p. 99 |
Aldosterone Antagonists | p. 100 |
Beta Blocker | p. 101 |
Hydralazine | p. 102 |
Nesiritide | p. 102 |
Digoxin | p. 103 |
Inotropic Agents | p. 103 |
Arrhythmias | p. 104 |
Cardiac Resynchronization | p. 105 |
Overview | p. 106 |
Diastolic Heart Failure | p. 107 |
Definition | p. 107 |
Epidemiology | p. 107 |
Etiology and Diagnosis | p. 107 |
Management | p. 108 |
References | p. 109 |
Valvular Diseases | p. 113 |
Aortic Stenosis | p. 113 |
Etiology and Pathophysiology | p. 113 |
Clinical Features | p. 114 |
Treatment | p. 115 |
Aortic Regurgitation | p. 116 |
Etiology and Pathophysiology | p. 116 |
Clinical Features | p. 117 |
Treatment | p. 117 |
Mitral Stenosis | p. 118 |
Etiology and Pathophysiology | p. 118 |
Clinical Features | p. 119 |
Therapy | p. 120 |
Mitral Regurgitation | p. 121 |
Etiology and Pathophysiology | p. 121 |
Clinical Features | p. 122 |
Therapy | p. 123 |
Tricuspid Valve Disease | p. 124 |
Etiology and Pathophysiology | p. 124 |
Diagnosis and Treatment | p. 125 |
References | p. 125 |
Pericardial Diseases | p. 129 |
Acute Pericarditis | p. 129 |
Etiology and Pathophysiology | p. 129 |
Clinical Features | p. 129 |
Therapy | p. 130 |
Cardiac Tamponade | p. 131 |
Etiology and Pathophysiology | p. 131 |
Clinical Features | p. 131 |
Therapy | p. 132 |
Constrictive Pericarditis | p. 133 |
Etiology and Pathophysiology | p. 133 |
Therapy | p. 134 |
References | p. 134 |
Prevention of Bacterial Endocarditis | p. 137 |
References | p. 139 |
Hyperlopidemia | p. 141 |
Screening | p. 142 |
Risk Categories | p. 143 |
Very High Risk | p. 143 |
High Risk | p. 143 |
Moderately High risk | p. 143 |
Moderate Risk | p. 143 |
Low Risk | p. 145 |
Risk Factors | p. 145 |
Metabolic Syndrome | p. 146 |
Therapy | p. 146 |
Lipid-Lowering Drugs | p. 148 |
References | p. 150 |
Index | p. 153 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.